Audited Results of Emcure Pharmaceuticals Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	5,243.19	4,381.92	3,497.66	3,107.09	3,387.24
Manufacturing Expenses	103.67	99.86	88.73	80.41	72.46
Personnel Expenses	821.12	782.31	706.41	649.18	603.95
Selling Expenses	197.12	185.13	261.46	150.83	114.72
Administrative Expenses	757.71	660.37	636.19	462.90	386.83
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	4,118.44	3,735.09	3,055.76	2,668.59	2,592.57
Operating Profit	1,124.75	646.84	441.89	438.49	794.67
Other Recurring Income	209.52	118.81	138.26	125.35	132.68
Adjusted PBDIT	1,334.27	765.64	580.15	563.84	927.35
Financial Expenses	118.27	112.96	166.09	166.83	145.14
Depreciation	246.73	224.97	204.83	178.52	165.79
Other Write offs	0	0	0	0	0
Adjusted PBT	969.26	427.71	209.23	218.48	616.42
Tax Charges	211.23	110.58	39.08	52.28	169.61
Adjusted PAT	758.03	317.13	170.15	166.21	446.81
Non Recurring Items	-24.42	-1.21	-14.65	-2.08	-0.79
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	732.96	317.13	160.83	160.06	446.81
Equity Dividend	56.85	0	54.26	36.17	54.26
Preference Dividend	0	0	0	0	0
Retained Earnings	2,687.75	2,011	1,695.08	1,593.84	2,268.88

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article